Stem cells have emerged as promising tools for the treatment of incurable neural and heart
diseases and tissue damage. However, the survival of transplanted stem cells is reported to …

Reactive oxygen species (ROS) have long been considered as pathological agents
inducing apoptosis under adverse culture conditions. However, recent findings have …

The long-term outlook for regenerative medicine predicts an increased need for scalable cell
expansion technologies that utilize non-animal derived materials and are compatible with …

Techniques to provide in vitro tissue culture have undergone significant changes during the
last decades, and current applications involve interactions of cells and organoids, three …

Human mesenchymal stem/stromal cells (MSC) are promising candidates for cell‐based
therapies and the development of microcarrier‐based cultures in scalable bioreactors with …

Human mesenchymal stem cells (hMSCs) have emerged as an important cell type in cell
therapy and tissue engineering. In these applications, maintaining the therapeutic properties …

Brain spheroids or organoids derived from human pluripotent stem cells (hiPSCs) are still
not capable of completely recapitulating in vivo human brain tissue, and one of the …

The ability of stem cells for self‐renewing, differentiation, and regeneration of injured tissues
is believed to occur via the hormetic modulation of nuclear/mitochondrial signal …

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous
system (CNS) which predominantly affect young adults and undergo heavy socioeconomic …

Previous views of reactive oxygen species (ROS) depicted them as harmful byproducts of
metabolism as uncontrolled levels of ROS can lead to DNA damage and cell death …